Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

U. K. pharmaceutical giant GSK on Tuesday struck a $10.

Source: [MarketWatch](https://www.marketwatch.com/story/gsk-just-announced-its-biggest-purchase-in-eight-years-to-rev-up-cancer-portfolio-it-had-previously-wound-down-a95e6065?mod=mw_rss_topstories)